OTC or DOA? –

January 18, 2019 –  The FDA has developed a model Drug Facts Label (DFL) with “easy-to-understand pictograms on how to use the drug” … “FDA’s development work here is extraordinary, and reflects their longstanding desire to see a pharmaceutical company take naloxone OTC  (over-the-counter),” says Amy Arthur, director of public and government relations at Harm Reduction Therapeutics, a non-profit trying to develop an over-the-counter naloxone product … with the FDA leading development and comprehension testing of the Naloxone DFL, “Responsibility now falls squarely on the shoulders of industry,”…

Full Story @ FilterMag.org